STC2 Is a Potential Prognostic Biomarker for Pancreatic Cancer and Promotes Migration and Invasion by Inducing Epithelial–Mesenchymal Transition

Figure 3

The effect of STC2 in migration and invasion of pancreatic cancer cells. (a) The transwell assay was used to test the effect of STC2 overexpression or knock-down in PANC-1 and HPAC cells. The right panel represents the mean cells in three fields of view. (b) The migration activity was assessed by the wound healing assay. The right panel shows the relative migration rate. The relative migration rate was quantified and compared with that of control cells. The respective cells with treatment were subjected as control cells. P<0.05 was significant difference between control cells. The results were represented as the mean ± standard deviation (n = 3).

(a)

(b)